Applications
Novartis Acquires Myricx for $1.5 Billion
Novartis has agreed to acquire UK-based biotech firm Myricx Bio for up to $1.5 billion. The deal focuses on gaining access to a new class of cancer-fighting drugs.
The Next Web (TNW) · 75d ago
Latest Biotech News & Updates
Protein folding, molecule generation and AI-native drug pipelines. The lab bench is going computational.
181 articles
Business
Huaheng Biotech Chair Guo Henghua Detained Over Fraud Case
Huaheng Biotech's actual controller, Guo Henghua, has been criminally detained by Hefei police. The detention is linked to a decade-old 'Qinguo' illegal fundraising case, causing the company to terminate its Hong Kong IPO plans.
虎嗅 · 78d ago
Business
Roche Launches Ras Overtaking Battle
Roche is aggressively advancing its Ras inhibitor pipeline, aiming to challenge existing market leaders in oncology treatment.
钛媒体 · 78d ago
Research
Artificial cell achieves limited rounds of cell division
Researchers have developed an artificial cell capable of undergoing a few rounds of division. The process requires significant external material input to sustain the division cycles.
Ars Technica · 79d ago
Business
Novo Nordisk Owner Backs Italian Drug Startup Fund
Novo Holdings is investing in an Italian fund to support drug startups, expanding its life sciences footprint beyond Denmark. This move continues the firm's strategy of investing in international deep-tech and biotech hubs.
The Next Web (TNW) · 79d ago
Research
Tumor genetic testing: Industry chaos and technical obsession
The tumor genetic testing industry faces scrutiny over irregular charging and 'large panel' technical obsessions that often lack clinical cost-effectiveness. Experts suggest shifting NGS capabilities toward drug R&D rather than excessive clinical screening.
虎嗅 · 80d ago
Research
US Navy Lab Unveils Portable DNA Threat Detection Device
The US Naval Research Laboratory has developed a portable device capable of identifying unknown biological threats, including engineered bioweapons, in under 30 minutes. The system utilizes rapid DNA and RNA analysis for field deployment.
cnBeta (Full RSS) · 84d ago
Research
New Antibiotic Megacluster Discovery Targets Superbugs
Researchers have identified a new "megacluster" of antibiotics, offering a promising strategy to combat antibiotic-resistant superbugs. This discovery represents a significant advancement in replenishing the medical arsenal against evolving bacterial threats.
Ars Technica · 85d ago
SetupAIResearch
Research
Colossal and US Government Partner on Endangered Species BioVault
Colossal Biosciences is collaborating with the US government to establish a 'BioVault' for endangered species. This initiative faces scrutiny amid broader political debates regarding environmental protection policies.
Wired · 86d ago
SetupAIResearch
Research
Crispr Inventor Questions AI's Role in Medical Innovation
The inventor of Crispr gene-editing technology has expressed skepticism regarding AI's ability to replace human effort in scientific discovery. This highlights a growing debate about the limits of AI in complex medical research.
Bloomberg Technology · 87d ago
Business
US-China Biotech Investment Faces Growing Geopolitical Scrutiny
Cross-border biotech deals between the US and China are becoming increasingly complex due to heightened regulatory scrutiny. Industry analysts predict a potential slowdown in investment and technology transfers as Washington tightens restrictions.
SCMP Technology · 90d ago
SetupAIBusiness
Business
BioNTech Founders' Spinout Sparks Investor Concern
Investor Bernd Förtsch is demanding transparency regarding the departure of BioNTech founders and the transfer of assets to their new venture. This highlights governance risks in high-stakes biotech AI firms.
Bloomberg Technology · 94d ago
Research
Longevity Startup Doses First Human to Reverse Aging
A longevity startup has initiated the first human clinical trial for its ER-100 technology. The treatment aims to reverse age-related cellular degradation and sight loss.
Wired · 102d ago
Business
Reid Hoffman to leave Microsoft board after decade
LinkedIn co-founder Reid Hoffman is stepping down from Microsoft's board of directors after nearly ten years. He plans to return to 'founder mode' to focus on his new drug-discovery startup, Manas AI.
GeekWire · 106d ago
Research
Google plans to release 64 million lab-bred mosquitoes
Alphabet subsidiary Verily has requested EPA approval to release millions of lab-bred mosquitoes in Florida and California. The project aims to combat dengue and Zika by using Wolbachia bacteria to reduce mosquito populations.
The Next Web (TNW) · 109d ago
Business
Moderna receives $50M for Ebola mRNA vaccine development
Moderna has been granted $50 million to accelerate the development of an mRNA-based vaccine targeting the Bundibugyo strain of Ebola. This initiative aims to address urgent public health needs during active outbreaks.
Ars Technica · 110d ago
Research
Akeso’s lung cancer drug shows 34% reduction in death risk
Akeso reported phase three clinical trial results for ivonescimab, demonstrating a 34% reduction in death risk for advanced squamous non-small cell lung cancer patients.
The Next Web (TNW) · 110d ago
Research
Akeso's ivonescimab shows strong results in lung cancer trials
Akeso's ivonescimab, a drug previously compared to a 'DeepSeek moment' for biotech, has demonstrated superior clinical results in treating non-small cell lung cancer. The positive phase three trial data positions the drug as a potential backbone therapy in the US$20 billion global market.
SCMP Technology · 110d ago
Research
Beyond PD-1: The New Frontier in Oncology
The oncology market is shifting away from traditional PD-1 therapies toward more advanced bispecific and trispecific antibodies. This transition marks a new era in cancer treatment innovation.
钛媒体 · 110d ago
Business
China Releases 2026 National Medical Insurance Catalog Adjustment Plan
The National Healthcare Security Administration has released the 2026 adjustment plan for the national medical insurance, maternity, and work-related injury drug catalogs. This update includes new negotiation rules for innovative drugs and commercial health insurance integration.
36氪 · 111d ago
Research
Single gene-editing dose slashes bad cholesterol by 62%
A small Phase I clinical trial shows that a single dose of a gene-editing drug can significantly reduce LDL cholesterol levels. The results suggest a potential breakthrough in treating cardiovascular disease through genetic intervention.
Ars Technica · 114d ago
Business
China accelerates domestic innovative drug approvals
China's drug regulator, the NMPA, has approved 19 innovative drugs so far this year, with 15 originating from domestic biotech firms. This shift highlights the rapid maturation of China's domestic pharmaceutical and biotech innovation ecosystem.
SCMP Technology · 115d ago
Research
Breakthrough in PI3Kα inhibitors for rare diseases
New research on PI3Kα inhibitors shows promising results in treating rare diseases. This development marks a significant step forward in targeted therapeutic interventions.
钛媒体 · 115d ago
Research
Roche's strategy for navigating neuroscience R&D challenges
Roche discusses its long-term commitment to neuroscience, focusing on overcoming the high failure rates and complexity inherent in brain-related drug development.
钛媒体 · 115d ago
SetupAIResearch
Research
Can AI Drug Development Live Up to the Hype?
Big Pharma companies are investing heavily in AI-driven drug discovery, but the industry is still waiting for concrete clinical results. The article questions whether current AI models can reliably accelerate the drug development pipeline.
Bloomberg Technology · 124d ago
Research
WHO declares Ebola emergency in DRC and Uganda
The WHO has declared a public health emergency due to an outbreak of the Bundibugyo Ebola virus in the DRC and Uganda. Current vaccines and antibody treatments developed for the Zaire strain are ineffective against this specific variant.
虎嗅 · 124d ago
Research
Global Pharma Market Shift: GLP-1 Drugs Dominate Revenue
Q1 2026 financial reports reveal a major shift in the pharmaceutical industry, with GLP-1 metabolic drugs propelling Eli Lilly and Novo Nordisk to the top, while traditional giants struggle with patent cliffs.
虎嗅 · 124d ago
Research
China releases first 20K Brassica napus gene chip
Jiangxi Academy of Agricultural Sciences released 'Zhongxinyou 1', China's first 20K solid-state gene chip for Brassica napus. This development ends two decades of foreign monopoly in solid-state chip technology for this crop.
cnBeta (Full RSS) · 127d ago
Research
GenSci161 receives FDA approval for clinical trials
GenSci161, a fully humanized bispecific antibody targeting IL-1α and IL-1β, has received FDA approval for clinical trials in the US. The drug is currently being studied for the treatment of hidradenitis suppurativa.
36氪 · 127d ago
SetupAIResearch
Research
Neuroscience of GLP-1 drugs and food noise
This article explores how GLP-1 drugs like semaglutide affect the brain's reward system to reduce 'food noise', alongside a detailed analysis of their side effects and long-term health implications.
虎嗅 · 127d ago